Results 211 to 220 of about 31,245 (262)
Some of the next articles are maybe not open access.
Economic Evaluation of Pharmaceuticals
PharmacoEconomics, 1992The increased pressures on health care budgets have emphasised the need to demonstrate the value for money from health technologies. Most major pharmaceutical companies have therefore commissioned cost-benefit or cost-effectiveness analysis of their products. There is an assumed analogy between clinical trains, which are required for product licensing,
openaire +4 more sources
Economic Evaluation of Pharmaceuticals
PharmacoEconomics, 1993In recent years there has been a large increase in the number of economic evaluations of pharmaceuticals. Many of these studies have been commissioned by individual pharmaceutical companies, in support of new or existing products. In 2 countries, Australia and Canada (in the province of Ontario), draft guidelines issued by the government have ...
Michael Drummond +10 more
openaire +2 more sources
The Economics of Pharmaceutical Policy in Ghana
International Journal of Health Services, 1980Pharmaceutical expenditure in Ghana accounts for about one-third of the total recurrent costs of the Ministry of Health, but in isolation this figure is a misleading indicator of economic importance. In the primary care sector up to 75–80 percent of the running cost of a health center may be accounted for by pharmaceuticals, and because the Ghanaian ...
A, Barnett, A L, Creese, E C, Ayivor
openaire +2 more sources
The Ethics and Economics of Pharmaceutical Pricing
Annual Review of Pharmacology and Toxicology, 2015The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices and find that advances in economic research have increased the sharpness and focus of the ethically based calls to increase access by modifying patent protection and ...
Sara, Parker-Lue +2 more
openaire +2 more sources
Economic analysis and pharmaceutical policy
Anaesthesia, 1995Summary Economic evaluation, a comparative analysis of alternative actions in terms of costs and consequences, allows rational decisions to be made concerning the deployment of resources (people, time, equipment, facilities and knowledge).
openaire +2 more sources
The Economics of Pharmaceutical Supply in Tanzania
International Journal of Health Services, 1980This paper analyzes the patterns of purchasing, distribution, and utilization of pharmaceuticals currently found in Tanzania, an underdeveloped country in Africa. Like other nations in the Third World, Tanzania offers the prospect of a rapidly expanding market for the multinational pharmaceutical industry.
openaire +2 more sources
Economic evaluation for pharmaceuticals in Germany
The European Journal of Health Economics, 2007Springer-Verlag 2007 With the new legislation in Germany, cost-benefit assessment can be used to stipulate maximum reimbursement amounts for pharmaceuticals. According to the law, the Institute for Quality and Efficiency in the Health Care Sector (IQWiG) can be commissioned by the Federal Joint Committee (G-BA) and the Ministry of Health with the ...
openaire +2 more sources
Pharmaceutical Economics [PDF]
Business Economics, 2008 The role economists play in shaping the direction and outcome of business research and policy decisions of a very important part of the healthcare industry—the pharmaceutical industry.Business Economics (2008) 43, 65–68; doi:10.2145 ...
openaire
Economics and Structure of the Generic Pharmaceutical Industry
Journal of the American Pharmaceutical Association (1996), 2001To review key economic trends of the generic medication market and analyze the changing structure of the generic medication industry.Articles were indexed initially using terms such as generic medications, generic drugs, multisource medications, and multisource drugs.
D M, Kirking +3 more
openaire +2 more sources
Pharmaceutical Economics And Policy
2006Abstract The pharmaceutical industry is praised as a world leader in high technology innovation and the creator of products that increase both longevity and quality of life for people throughout the world. At the same time, the industry is also criticized for its marketing and pricing practices and for its apparent anticompetitive ...
openaire +1 more source